Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Innovation Adoption Is Key UK Challenge Says MedTech Directorate

Standing still is not an option if the health care system is to remain sustainable

Executive Summary

The UK’s MedTech Directorate is pressing ahead with 16 separate initiatives under its recently issued medtech strategy. It all adds to the sense that 2023 will be a major year for UK medtech.

You may also be interested in...



Why NICE Is Building The Medtech Innovation Plane As It Flies

England’s NICE is ditching the rulebook in favor of “failing forward faster” when it comes to tackling medtech innovations. The organization’s interim director of medical technology says this approach mirrors the entrepreneurial nature of the medtech, diagnostics and digital sectors.

UK Sets Out Landscape For Uptake Of Appropriate Medtech Innovation

The UK MedTech Directorate’s value-based strategy has been conceived to address resilience and improve the adoption and spread of medtech in the UK. But it should also provide the impetus to embed the digital, bespoke manufacturing and modern medtech industry segments, says the Medical Technology Group.

Here Comes The NICE Revolution – Agility And Speed Will Drive UK HTA Into A New Era

Evolving health care demands, digital innovation and the need to work within tighter budgets have prompted the UK’s NICE to reset its strategy for the coming five years.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147716

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel